India Malaria Diagnostics Market (By Technology: RDTs, Microscopy, Molecular Diagnostic Tests; By End Use: Hospitals & Clinics, Diagnostic Laboratories) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The India malaria diagnostics market was valued at USD 20.3 million in 2021 and it is predicted to surpass around USD 29.96 million by 2030 with a CAGR of 4.42% from 2022 to 2030

Key drivers of the market include rising demand for malaria diagnostics, introduction of novel diagnostic techniques, and increasing prevalence of the disease in the nation.

Increasing initiatives undertaken by the government is anticipated to propel market growth during the forecast period. The government of India has been committed to achieving malaria free recognition by 2027. Highest prevalence of the disease is typically seen across states such as Arunachal Pradesh, Jharkhand, Maharashtra, Tripura, Madhya Pradesh, Dadar & Nagar Haveli, Meghalaya, Mizoram, and Odisha.

The Micro Strategic Plan for Malaria Elimination in the State of Punjab, India (2018-2020) was developed by the National Vector Borne Disease Control Program and the State Government of Punjab in collaboration with WHO Country Office of India and National Vector Borne Disease Control Program, Delhi. In alignment with the National Strategic Plan for Malaria Elimination (2017-2022), the Government of Punjab launched a state-specific Strategic Action Plan (SAP) to eliminate the disease. The goal of this SAP is to achieve zero malaria transmission by 2020 and ensure prevention of reintroduction of the disease after 2020. Some of the objectives of SAP in Punjab are, reduction of disease incidence to zero indigenous cases to achieve malaria free status in the state, reduction in the number of active disease foci to zero level, and maintaining zero deaths caused by malaria. Thus, rise in such initiatives by the government to curb the disease is anticipated to fuel market growth.

Rising demand for diagnostic tools in malaria-endemic countries such as India, is one of the major factors accelerating market growth. According to the World Malaria Report published by WHO, India contributed to around 4% of the total cases and 48% of Plasmodium vivax infections globally. According to a research study published by the National Center for Biotechnology Information (NCBI), almost 70% of malaria cases were reported by five states, namely, Chhattisgarh, Madhya Pradesh, Odisha, Jharkhand, and Maharashtra. Hilly and tribal areas of the country such as Meghalaya, Nagaland, and Mizoram also exhibit high prevalence of the disease. These facts are indicative of the chronic burden of the disease in endemic countries, making it an urgent health priority in these regions.

Increasing initiatives undertaken by market players to reduce disease prevalence is also one of the major factors driving the market. For instance, Abbott Laboratories and a non-profit group called “Malaria No More” are providing the Odisha government with one million RDTs. In addition, Abbott Laboratories is contributing USD 750,000 to the non-profit group, facilitating the government of Odisha’s Vector Borne Disease Control Program. Such initiatives are expected to facilitate the development of new and advanced diagnostic technologies and product launches.

Scope of The Report

Technology Insights

Based on technology, the India malaria diagnostics market is segmented into rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics segment is expected to witness the fastest growth owing to accurate diagnosis offered by these tests. Molecular diagnostic tests include real-time PCR or quantitative PCR (qPCR) and Polymerase Chain Reaction (PCR). The usage of real-time PCR using DNA extracted from the blood samples have been used for the detection of low parasite count. However, the market share of these tests is less due to the lack of skilled workforce and specialized laboratories in India.

The microscopy method is also expected to grow owing to the rise in the use of microscopy techniques for the diagnosis of the disease. This technique is one of the most reliable and traditional methods used for disease diagnosis. Malarial parasites such as P. malaria, P. vivax, P. falciparum, and P. ovale can be identified using this technique. Also, parasite density can be quantified to design treatment plans accordingly.

Rapid diagnostic tests are another method that is used for the detection of specific malaria antigens from the blood sample. This test makes use of a test card, wherein the blood sample is applied along with specific reagents. The appearance of specific bands in the test card, within 15 to 20 minutes, indicates the presence of infection with either of the human malarial parasites. These RDTs are capable of detecting P. falciparum, P. malariae, P. ovale, and P. vivax species of human malaria. Malarial RDTs are typically used where microscopy examination is not feasible, especially in remote areas with limited access to healthcare infrastructure and high-quality microscopy services.

End-use Insights

Based on end-use, the market is segmented into hospitals and clinics, diagnostic laboratories, blood banks, and academic and research institutes. The hospitals and clinics segment accounted for the largest market share in 2021 as the majority of the population relies on these long-term facilities for diagnosis, treatment, and management of diseases. In urban India, the easy availability of diagnostic devices, awareness, and experienced healthcare professionals facilitates the easy and effective treatment of malaria. In these areas, malaria is generally prevalent during and post monsoons between July and October. In urban areas, the disease outbreak is highly prevalent due to prolonged rainfall and climatic changes that facilitate the easy growth of Anopheles mosquitoes. Most of the urban regions in India seek treatment in privatized healthcare settings as they are well equipped with advanced diagnostic techniques and provide timely treatment. Thus, the hospitals and clinics segment is anticipated to witness significant growth during the forecast period.

The blood bank segment is expected to witness steady growth during the forecast period. For infectious diseases such as malaria, influenza, and dengue, typically, blood donors are inquired regarding recent visits to endemic regions. In most cases, rapid diagnostic tests are used as primary screening tests, and serological tests are done post confirmatory results. Blood samples from the donor are analyzed and other disease illnesses are determined before blood transfusions. A rise in the number of surgical procedures has been reported in India, which can be attributed to the increase in the incidence of severe chronic diseases and accidents. This has created a significant demand for blood donations in the nation, facilitating increased demand for malarial diagnostic devices.

Key Players

• Abbott Laboratories
• Siemens Healthineers
• Bio-Rad Laboratories
• Beckman Coulter, Inc.
• Access Bio, Inc.
• Premier Medical Corporation Pvt. Ltd.
• Olympus Corporation
• Nikon Corporation
• J. Mitra & Co. Pvt. Ltd.
• Tulip Diagnostics Ltd.
• Microgene Diagnostic Systems Pvt. Ltd.

Market Segmentation

• By Technology Outlook

• Microscopy
• Rapid Diagnostic Tests (RDT)
• Molecular Diagnostic Tests

• Conventional PCR
• Real-Time PCR (qPCR or quantitative PCR)
• By End-use Outlook
• Hospitals & Clinics
• Diagnostic Laboratories
• Blood Banks
• Academic and Research Institutes